Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01732406 · ClinicalTrials.gov registry record
Acromegaly Treatment Quality of Life Study
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 126
- Enrollment target
NCT01732406: Completed study, sponsored by Massachusetts General Hospital.
NCT01732406 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01732406 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
The investigators hypothesize that treatment of acromegaly will be associated with an improvement in quality of life compared to active acromegaly. At the same time, they will also be studying the effects of different acromegaly treatments on the quality of life.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-12-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01732406
The ClinicalTrials.gov registry entry for NCT01732406 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01732406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01732406 about?
NCT01732406 is a clinical study titled "Acromegaly Treatment Quality of Life Study". The investigators hypothesize that treatment of acromegaly will be associated with an improvement in quality of life compared to active acromegaly. At the same time, they will also be studying the effects of different acromegaly treatments on the quality of life.
What is the current status of trial NCT01732406?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2013-01. Estimated completion is 2016-12-19.
Who is sponsoring clinical trial NCT01732406?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.